Showing results (1161-1170 of 1,408) with videos related to
Sort By:
Pageof 141
Blood|May 11, 2006
Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapyH Joachim Deeg, Margaret O'Donnell, Jakub Tolar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2010
Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantationPaul J Martin, George W Counts, Frederick R Appelbaum, et al.Nature Communications|December 21, 2023
Distinct gene expression signatures comparing latent tuberculosis infection with different routes of Bacillus Calmette-Guérin vaccinationRichard F Silver, Mei Xia, Chad E Storer, et al.Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
In search of effective therapies to overcome resistance to Temozolomide in brain tumoursKaouthar Bouzinab, Helen Summers, Jihong Zhang, et al.Transplantation|September 14, 2006
Partial donor-specific tolerance to delayed skin grafts after rejection of hematopoietic cell graftMurad Y Yunusov, Christian S Kuhr, George E Georges, et al.Memorias Do Instituto Oswaldo Cruz|January 9, 2013
Cells and mediators of inflammation (C-reactive protein, nitric oxide, platelets and neutrophils) in the acute and convalescent phases of uncomplicated Plasmodium vivax and Plasmodium falciparum infectionJosué da Costa Lima-Junior, Rodrigo Nunes Rodrigues-da-Silva, Virgínia Araújo Pereira, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2019
The Chronic Graft-versus-Host Disease Failure-Free Survival (cGVHD-FFS) IndexJoseph A Pidala, Betty K Hamilton, Paul J Martin, et al.Journal of the American Chemical Society|July 30, 2025
Modular Synthetic Platform for the Elaboration of Fragments in Three Dimensions for Fragment-Based Drug DiscoveryAndres R Gomez-Angel, Hanna F Klein, Stephen Y Yao, et al.Haematologica|April 22, 2011
Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemiaRon Ram, Rainer Storb, Brenda M Sandmaier, et al.Journal of Oncology Practice|September 23, 2010
Benchmarks in clinical productivity: a national comprehensive cancer network surveyF Marc Stewart, Robert L Wasserman, Clara D Bloomfield, et al.Pageof 141